7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5 Remdesivir Intermediate COVID-19

Description:

Chemical Name: 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine

CAS: 937046-98-5

Aspectus: Lumen Yellow Pulvis

Puritas: ≥97.0%

Medium Remdesiviri (CAS 1809249-37-3) COVID-19

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine
Synonyma 4-Amino-7-bromopyrrolo[2,1-f][1,2,4]triazine;Remdesivir Impuritas 2
CAS Number 937046-98-5
CATTUS Number RF-PI305
Stock Status In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae C6H5BrN4
M. Pondus 213.04
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Lumen Yellow Pulvis
Infrared Imaginis Conformat ut Structure
NMR Conformat ut Structure
Puritas ≥97.0%
Damnum in Siccatio ≤1.0
una immunditia ≤1.0%
Metalla gravis ≤20ppm
Test Standard Enterprise Standard
Consuetudinem Intermedia Remdesiviri (CAS 1809249-37-3)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

1

FAQ:

Applicatio:

7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine (CAS 937046-98-5) est medius Remdesivir (CAS 1809249-37-3).Remdesivir est pharmacum antivirale cum actione coronavirus 2 syndrome respiratorii acuto contra acutum (SARS-CoV-2).Remdesivir (etiam notus ut Veklury vel GS-5734) est SARS-CoV-2 nucleotide analog RNA polymerasis inhibitor indicatus pro aegris adultis et pediatricibus (XII annis etatis et maioribus et saltem 40 kg) ad tractationem morborum coronavirorum MMXIX. (COVID-19) hospitalizationem postulantes.Remdesivir solum in nosocomio vel in adiunctis valetudinariis administrari debet idoneum curam acrem curare comparandum cum inpatienti hospitali cura.Remdesivir primum evolvit ut anti-virale contra virus Ebola, sed cum ostensum est onera viralium attenuata plurium RNA virus syncytialium respiratorii (RSV) et β-coronaviri sicut SARS-CoV, MERS-CoV, et causativum agentis COVID-XIX, SARS-CoV-II.

Epistulam tuam hic scribe et mitte nobis